Similar articles for PMID: 24499553

Year	Number of Results
1988	1
1990	2
1991	1
1992	1
1993	3
1994	2
1995	1
1996	4
1997	3
1998	4
1999	2
2000	3
2002	1
2003	1
2004	3
2005	2
2006	3
2007	4
2008	5
2009	4
2010	4
2011	5
2012	6
2013	6
2014	3
2015	8
2016	6
2017	5
2018	6
2019	3
2020	1
2021	2
2024	0

1

Radioprotective effects of oral 17-dimethylaminoethylamino-17-demethoxygeldanamycin in mice: bone marrow and small intestine.

Lu X, Nurmemet D, Bolduc DL, Elliott TB, Kiang JG. Lu X, et al. Cell Biosci. 2013 Sep 16;3(1):36. doi: 10.1186/2045-3701-3-36. Cell Biosci. 2013. PMID: 24499553 Free PMC article.

2

Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.

Glaze ER, Lambert AL, Smith AC, Page JG, Johnson WD, McCormick DL, Brown AP, Levine BS, Covey JM, Egorin MJ, Eiseman JL, Holleran JL, Sausville EA, Tomaszewski JE. Glaze ER, et al. Cancer Chemother Pharmacol. 2005 Dec;56(6):637-47. doi: 10.1007/s00280-005-1000-9. Epub 2005 Jun 29. Cancer Chemother Pharmacol. 2005. PMID: 15986212

3

Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage.

Liu W, Chen Q, Wu S, Xia X, Wu A, Cui F, Gu YP, Zhang X, Cao J. Liu W, et al. J Radiat Res. 2015 Mar;56(2):278-86. doi: 10.1093/jrr/rru100. Epub 2015 Jan 23. J Radiat Res. 2015. PMID: 25617317 Free PMC article.

4

17α-Ethinyl-androst-5-ene-3β, 17β-diol, a Novel Potent Oral Radioprotective Agent, Confers Radioprotection of Hematopoietic Stem and Progenitor Cells in a Granulocyte Colony-Stimulating Factor-Independent Manner.

Bai F, Wang L, Li Z, Yi L, Zuo Z, Zhang C, Shan Y, Yang C, Peng R, Yang R, Yu Z, Cong Y. Bai F, et al. Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):217-228. doi: 10.1016/j.ijrobp.2018.08.002. Epub 2018 Aug 10. Int J Radiat Oncol Biol Phys. 2019. PMID: 30103023 Free article.

5

Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.

Kaur G, Belotti D, Burger AM, Fisher-Nielson K, Borsotti P, Riccardi E, Thillainathan J, Hollingshead M, Sausville EA, Giavazzi R. Kaur G, et al. Clin Cancer Res. 2004 Jul 15;10(14):4813-21. doi: 10.1158/1078-0432.CCR-03-0795. Clin Cancer Res. 2004. PMID: 15269157

6

Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin.

Bull EE, Dote H, Brady KJ, Burgan WE, Carter DJ, Cerra MA, Oswald KA, Hollingshead MG, Camphausen K, Tofilon PJ. Bull EE, et al. Clin Cancer Res. 2004 Dec 1;10(23):8077-84. doi: 10.1158/1078-0432.CCR-04-1212. Clin Cancer Res. 2004. PMID: 15585643

7

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative.

Hollingshead M, Alley M, Burger AM, Borgel S, Pacula-Cox C, Fiebig HH, Sausville EA. Hollingshead M, et al. Cancer Chemother Pharmacol. 2005 Aug;56(2):115-25. doi: 10.1007/s00280-004-0939-2. Epub 2005 Mar 25. Cancer Chemother Pharmacol. 2005. PMID: 15791458

8

In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice.

Uckun FM, Souza L, Waddick KG, Wick M, Song CW. Uckun FM, et al. Blood. 1990 Feb 1;75(3):638-45. Blood. 1990. PMID: 1688721 Free article.

9

Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors.

Aregbe AO, Sherer EA, Egorin MJ, Scher HI, Solit DB, Ramanathan RK, Ramalingam S, Belani CP, Ivy PS, Bies RR. Aregbe AO, et al. Cancer Chemother Pharmacol. 2012 Jul;70(1):201-5. doi: 10.1007/s00280-012-1859-1. Epub 2012 Mar 27. Cancer Chemother Pharmacol. 2012. PMID: 22450873 Free PMC article. Clinical Trial.

10

Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.

Schwock J, Pham NA, Cao MP, Hedley DW. Schwock J, et al. Cancer Chemother Pharmacol. 2008 Apr;61(4):669-81. doi: 10.1007/s00280-007-0522-8. Epub 2007 Jun 20. Cancer Chemother Pharmacol. 2008. PMID: 17579866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year